Mostrando 10 resultados de: 14
Filtros aplicados
Publisher
Elsevier(5)
AMER ASSOC BLOOD BANKS(1)
American Society for Microbiology Journals(1)
Taylor & Francis(1)
Universidad Central del Ecuador(1)
Área temáticas
Enfermedades(9)
Medicina forense; incidencia de enfermedades(7)
Ganadería(5)
Microorganismos, hongos y algas(5)
Farmacología y terapéutica(4)
A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN)
OtherAbstract: Protection against canine kala-azar was investigated in naturally exposed dogs of an endemic area, vPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleConhecimento, Percepções de Indivíduos em Relação à Leishmaniose Visceral Humana Como Novas Ferramentas de Controle Knowledge, Perceptions of Individuals Regarding to Human …
OtherAbstract: O Brasil sofre atualmente um sério problema de saúde pública quanto à leishmaniose visceral humana (Palabras claves:Autores:Gulnara Borja-CabreraFuentes:googleCross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis
OtherAbstract: The fucose-mannose ligand (FML) complex of Leishmania donovani is a promising vaccine candidate agaiPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleEstudio de factores de riesgo para transmisión de leishmaniosis cutánea americana en una área endémica de la Provincia de Pichincha
ArticleAbstract: Contexto: En Ecuador, la leishmaniosis cutánea americana se reporta en 20 de 22 provincias, con unaPalabras claves:ACTITUDES, attitudes, conocimientos, Cutaneous leishmaniasis, epidemiology, epiolemiología, FACTORES DE RIESGO, knowledge, Leishmaniosis cutánea, PICHINCHA, PRACTICAS, practices, RISK FACTORSAutores:Bryan Suárez, Gabriela Robles, Gulnara Borja-Cabrera, Jessica Gómez, Jorge Quinchuela, Jorge Tufiño, Soraya RiveraFuentes:googlerraaeFML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
OtherAbstract: The Leishmania donovani glycoprotein fraction, known as FML, successfully underwent preclinical andPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleOccurrence of Leishmania donovani DNA in bone marrow of FML-seroreactive Brazilian blood donors.
OtherAbstract:Palabras claves:Autores:Gulnara Borja-CabreraFuentes:googleParaguai de Souza E, Santos WR, Gomes EM, et al. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo …
OtherAbstract:Palabras claves:Autores:Gulnara Borja-CabreraFuentes:googleImmunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune® vaccine
OtherAbstract: In order to assess the immunotherapeutic potential on canine visceral leishmaniasis of the LeishmunePalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleLeishmune® vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs
OtherAbstract: Leishmune® vaccine is the first licensed vaccine against canine visceral leishmaniasis. It containsPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleLong lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)
OtherAbstract: Naturally exposed dogs of an endemic area were vaccinated with the fucose mannose ligand (FML) antigPalabras claves:Autores:Gulnara Borja-CabreraFuentes:google